Erytech Pharma S.A. — Form D
Erytech Pharma S.A. of LYON, I0, a company, filed a Form D exempt-offering notice with the SEC on 2014-11-07. $37.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-11-07
- Form: D
- Accession: 0001624422-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $37.2M
- Investors: 33
- Date of first sale: 2014-10-24
- Revenue range: No Revenues
- SEC file number: 021-227905
Issuer
- Name: Erytech Pharma S.A.
- CIK: 0001624422
- Entity type: Corporation
- Jurisdiction: FRANCE
- Address: 60 AVENUE ROCKEFELLER, LYON, I0, 69008
- Phone: 011-33-4-78-74-44-38
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| J?r?me BAILLY | Director | CHASSIEU, I0 |
| None BRYAN GARNIER & CO | Promoter | LONDON, X0 |
| None LifeSci Capital | Promoter | NEW YORK, NY |
| Luc Dochez | Director | NEW YORK, NY |
| GIL BEYEN | Director | LYON, I0 |
| GIL BEYEN | Executive Officer | LYON, I0 |
| MARTINE GEORGE | Director | LYON, I0 |
| SVEN ANDREASSON | Director | LYON, I0 |
| HILDE WINDELS | Director | LYON, I0 |
| YANN GODFRIN | Director | LYON, I0 |
| YANN GODFRIN | Executive Officer | LYON, I0 |
| YANN GODFRIN | Promoter | LYON, I0 |
| ERIC SOYER | Executive Officer | LYON, I0 |
| PHILIPPE ARCHINARD | Director | LYON, I0 |
| JEROME BAILLY | Executive Officer | LYON, I0 |
| None GALENOS | Director | IXELLES, C9 |
| Pierre-Olivier GOINEAU | Director | LYON, I0 |
| Pierre-Olivier GOINEAU | Executive Officer | LYON, I0 |
| Pierre-Olivier GOINEAU | Promoter | LYON, I0 |
Other filings by this issuer (2)
More